NovoCure Stock (NASDAQ: NVCR) stock price, news, charts, stock research, profile.
Open | $11.890 |
Close | $12.090 |
Volume / Avg. | 850.446K / 1.384M |
Day Range | 11.890 - 12.320 |
52 Wk Range | 10.870 - 83.600 |
Market Cap | $1.303B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 6.51% |
Days to Cover | 2.05 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NovoCure (NASDAQ: NVCR) through any online brokerage.
Other companies in NovoCure’s space includes: SI-BONE (NASDAQ:SIBN), Varex Imaging (NASDAQ:VREX), Envista Holdings (NYSE:NVST), Inari Medical (NASDAQ:NARI) and Alphatec Holdings (NASDAQ:ATEC).
The latest price target for NovoCure (NASDAQ: NVCR) was reported by Piper Sandler on Wednesday, April 10, 2024. The analyst firm set a price target for 28.00 expecting NVCR to rise to within 12 months (a possible 130.07% upside). 21 analyst firms have reported ratings in the last year.
The stock price for NovoCure (NASDAQ: NVCR) is $12.17 last updated April 19, 2024 at 5:22 PM EDT.
There are no upcoming dividends for NovoCure.
NovoCure’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for NovoCure.
NovoCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.